| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 16/02/2007 | 14:30 | PR Newswire (US) | GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 15/02/2007 | 15:00 | PR Newswire (US) | GlaxoSmithKline Extends Subsequent Offering Period By One Day | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 07/02/2007 | 15:11 | PR Newswire (US) | GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 09/01/2007 | 15:03 | PR Newswire (US) | GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 09/11/2006 | 13:15 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 08/11/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Interim Clinical Data on PPI-2458 at the 18th EORTC-NCI-AACR Symposium | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 01/11/2006 | 20:02 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter Financial Results on Thursday, November 9, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 24/10/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Receives the Cerep Award for Research Related to Its Investigational Drug Candidate, PPI-24 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 18/10/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 04/08/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 01/08/2006 | 22:30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED to Announce Second Quarter Financial Results on Friday, August 4, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 20/06/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Cessation of Plenaxis(R) Disposition Efforts; Plans to Explore Financing Alterna | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 05/05/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2006 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 28/04/2006 | 13:30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce First Quarter Financial Results on Friday, May 5, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 20/04/2006 | 14:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Appoints Prem Das as Senior Vice President, Technology Partnerships | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 10/04/2006 | 13:30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Pilot Study and Option Agreement with GlaxoSmithKline to Utilize DirectSelect(TM | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 21/03/2006 | 13:30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Technology Transfer and Option Agreement with Gilead Sciences, Inc. to Utilize D | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 15/03/2006 | 14:30 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Update on its DirectSelect(TM) Technology | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 09/03/2006 | 20:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Presents Preclinical Data on PPI-2458 in Rheumatoid Arthritis | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 03/02/2006 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Fourth Quarter and Year End 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 30/01/2006 | 20:40 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Fourth Quarter and Year End 2005 Financial Results on Friday, February 3, 2006 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 08/11/2005 | 00:15 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 9, | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 04/11/2005 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Third Quarter 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 01/11/2005 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED To Announce Third Quarter 2005 Financial Results on Friday, November 4, 2005 | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 27/10/2005 | 22:17 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Stockholders Authorize Reverse Stock Split; Board Sets 1-for-5 Split Ratio | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 19/10/2005 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Completes Sale of Facility for $51.25 Million | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 11/10/2005 | 15:12 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement for Sale of Facility | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 29/09/2005 | 02:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Announces German Regulatory Approval for Plenaxis(R); Schering AG Collaboration Terminated | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 05/08/2005 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports Second Quarter 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |
| 06/05/2005 | 13:00 | Business Wire | PRAECIS PHARMACEUTICALS INCORPORATED Reports First Quarter 2005 Financial Results | NASDAQ:PRCS | Praecis Pharmaceuticals (MM) |